Drug Development Partner
Parimer is a Drug Substance development company that specializes in the design, development, and manufacturing of new chemical entities to treat human diseases. Our cGMP suites support clients in their development, clinical, and full commercial API efforts with client sizes ranging from 1 employee to clients with 10,000 employees.
Let our expert, scientist-led teams work with you on the navigation of IND, CMC, ICH, FDA, ISO, and other regulatory challenges from the start, ensuring a seamless journey from development to commercialization.
Parimer's Breadth of Expertise
Regulatory
Parimer's team will happily share the expertise gained by helping dozens of biotechnology clients enter the market
Excipients
Parimer's team is experienced in polymers, polysaccharides, and other monographed excipients
Small Molecules
Parimer is capable of manufacturing chemical compounds for human use under 21 CFR 211
Medical Devices
Liquid Medical Devices including both FDA 510k and DeNovo Registration per 21 CFR 820
What makes Parimer Different?
Parimer is a small privately held US owned and operated company. We are small enough to be nimble and give each client personal executive attention while large enough to navigate the onerous FDA requirements for API development. We pride our selves on being lean and competitive on pricing and will often price match any competitor (provided they are registered with the FDA for API manufacturing in the USA) We even waive any rights to ownership for intellectual property developed under contract and will often work with startup companies by accepting some degree of equity in exchange for services. Overall, our team is here to help bring your product to market.
Our vision is to help small business, academia and bio pharma startups cost effectively scale new innovation.
Certified Experts
FDA Registered, ISO Accredited, DEA Licensed, cGMP compliant, led by PhD experts with a dedicated regulatory department ensuring highest standards.
